Pharmacological considerations when treating hypertensive patients for osteoarthritis-Reference-Cited by-同舟云学术

Pharmacological considerations when treating hypertensive patients for osteoarthritis

Published:2022-10-12 Issue:15 Volume:23 Page:1673-1676
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Piszczatoski Christopher R¹^ORCID,Smith Steven M²^ORCID

Affiliation:

1. UF Health Physicians, University of Florida, Gainesville, FL, USA

2. Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL, USA

Funder

No funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2133601

Reference19 articles.

1. Osteoarthritis [Internet]. Geneva: World Health Organization. 2013. [cited 2022 Jan 31]. Available from: https://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf

2. Treatment strategies for osteoarthritis patients with pain and hypertension

3. Association between hypertension and osteoarthritis: A systematic review and meta-analysis of observational studies

4. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis

5. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016;The Journal of Pain;2023-11

2. Evaluation of the efficacy and safety of various non-steroidal anti-inflammatory drugs in postmenopausal women with an inflammatory phenotype of osteoarthritis;Meditsinskiy sovet = Medical Council;2023-10-20